MCL Featured Stories
In March 2018, Mayo Medical Laboratories announced fifteen new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
Justin Kreuter, M.D., Clinical Pathologist and Medical Director of the Mayo Clinic Blood Donor Center in Rochester, Minnesota, highlights inter-professional collaboration through a recap of #Transfuse18.
A breakthrough in pathology, achieved more than a century ago (allegedly on a frozen window ledge in Rochester, Minnesota) has evolved into an innovative aspect of care at Mayo Clinic. Mayo is one of the only medical centers in the United States to routinely use a tissue-freezing process that provides analysis of tissue samples while the patient is still in the operating room.
Mike Baisch, Principal Systems Engineer at Mayo Clinic, discusses staffing to workload in phlebotomy areas with a focus on indirect effort, which includes tasks performed that don’t involve the patient or a patient’s sample.
In February 2018, Mayo Medical Laboratories announced two new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
There have been concerns in the U.S. recently about the possible harmful side effects from absorbing gadolinium-based contrast agents into the body during some MRI exams. To address some of the anxiety and concerns over this issue, Paul Jannetto, Ph.D., DABCC, FAACC, and Joshua Bornhorst, Ph.D., DABCC, FAACC, Co-Directors of the Mayo Clinic Metals Laboratory and leading experts in this field, have compiled the following list of the most up-to-date information.
In January 2018, Mayo Medical Laboratories announced five new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
By taking into account an individual’s genes, lifestyle, and environment, precision medicine offers the prospect of finding individualized therapies that might ultimately cure diseases such as cancer and diabetes. Yet, as with other technological revolutions, precision medicine’s quest for innovation bumps up against a host of legal issues—for patients as well as laboratories and providers of care.
In December 2017, Mayo Medical Laboratories announced seven new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
This case presents a female patient in her 70s with pain in the right upper quadrant. An ultrasound showed pelviectasis bilaterally, right greater than left. What is the diagnosis?
Due to the Christmas holiday (recognized on Monday, Dec. 25) and the New Year's holiday (recognized on Monday, Jan. 1), Mayo Medical Laboratories’ specimen pickup and delivery schedules will be altered. To ensure that your specimen vitality and turnaround times are not affected, plan ahead and note that no pickups or deliveries will be made on Dec. 25 or Jan. 1 by Mayo couriers or by FedEx.
A recent Mayo Clinic study has found that many U.S. health care providers are habitually ordering a mostly unnecessary, and quite expensive, genetic test to identify a patient’s hereditary risk of venous thromboembolism.
Due to the Thanksgiving holiday in the United States (recognized on Thursday, Nov. 23), Mayo Medical Laboratories’ specimen pickup and delivery schedule will be altered. To ensure that your specimen vitality and turnaround time are not affected, plan ahead and note that no pickups or deliveries will be made on Nov. 23 by our couriers or FedEx.